Siemens Healthineers, DE000SHL1006

Siemens Healthineers stock gets radiotherapy AI update

Published on 10/29/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
NVIDIA and Siemens Healthineers are developing adaptive radiotherapy with agentic planning and simulation. Siemens Healthineers stock costs EUR 42.96 on October 29, 2026.

Radiotherapy collaboration and dates

  • Siemens Healthineers and NVIDIA announced their adaptive radiotherapy collaboration on October 21, 2026.
  • Siemens Healthineers ended general imaging ultrasound sales on October 12, 2026, to concentrate on procedural imaging.
  • Siemens Healthineers stock trades at EUR 42.96 at 11:01 a.m. CEST at Lang & Schwarz on October 29, 2026, 0.87 percent above the Xetra close of October 28, 2026.
Siemens Healthineers, DE000SHL1006, Illustration mit AI erstellt.

Siemens Healthineers stock gets a radiotherapy AI update as the company and NVIDIA work on adaptive treatment planning. In a release dated October 21, 2026, NVIDIA said the collaboration combines Siemens Healthineers imaging and oncology expertise with accelerated computing and simulation.

What the collaboration develops

The project is focused on agentic co-planning, patient-specific simulation and real-time computing. NVIDIA said Nemotron foundation models are being explored for co-planning, while CUDA-accelerated dose calculation and the Holoscan platform could support faster simulation and live sensor processing.

The companies describe development work rather than a disclosed revenue contract. The release says the aim is to simplify radiotherapy workflows and expand access to personalized cancer care, while the technology remains subject to further development.

Why the ultrasound shift matters

Siemens Healthineers is also narrowing its ultrasound strategy. Its official October 12, 2026 release says general imaging ultrasound sales ended on October 12, while the company is concentrating on procedural imaging, cardiovascular interventions, software, artificial intelligence and partnerships.

The ultrasound portfolio continues to include the Acuson Origin, P500 and Freestyle systems for procedural customers. Siemens Healthineers said it will continue service, maintenance, software updates and transducer availability for its installed base.

Upcoming reporting date

The investor-relations calendar lists fourth-quarter fiscal 2026 results and an analyst call for November 5, 2026, followed by a US roadshow on November 6, 2026. Those dates offer the next scheduled checkpoints for the group's operating picture and the commercial progress of its technology programs.

Stock trades above the Xetra close

At 11:01 a.m. CEST on October 29, 2026, Siemens Healthineers stock was trading at EUR 42.96 at Lang & Schwarz, up 0.87 percent versus the Xetra close of October 28, 2026, at EUR 42.59. The current quote is EUR 6.74 below the 52-week high of EUR 49.70 shown for the same Xetra instrument.

The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.

Siemens Healthineers facts

  • Company: Siemens Healthineers AG
  • ISIN: DE000SHL1006
  • Ticker: SHL
  • Price Lang & Schwarz (as of October 29, 2026, 11:01 a.m. CEST): EUR 42.96
  • Change versus Xetra close: plus 0.87 percent
  • Xetra close (October 28, 2026): EUR 42.59
  • 52-week range: EUR 32.81-49.70
  • Sector / Industry: Healthcare / Medical Devices

Market context: Market report DAX.

More news and analyses on Siemens Healthineers stock

Disclaimer...
en | DE000SHL1006 | SIEMENS HEALTHINEERS | boerse | 70427404 |